Stefania Comi

Stefania Comi

Auto-generated profile, based on publicly available information

Stefania Comi

Unit of Medical Physics, European Institute of Oncology, Milan, Italy

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
RLRoberta Lazzari
Roberta Lazzari
SRSara Ronchi
Sara Ronchi
Sara GandiniSara Gandini
Sara Gandini
Alessia SurgoAlessia Surgo
Alessia Surgo
Stefania VolpeStefania Volpe
Stefania Volpe
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa

1 November 2012 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
MPMarta Peroni
Marta Peroni
DCDelia Ciardo
Delia Ciardo
MSMaria Francesca Spadea
Maria Francesca Spadea
MRMarco Riboldi
Marco Riboldi
SCStefania Comi
Stefania Comi
RORoberto Orecchia
Roberto Orecchia

1 August 2017 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
Giuseppe FanettiGiuseppe Fanetti
Giuseppe Fanetti
CFCristiana Fodor
Cristiana Fodor
DCDelia Ciardo
Delia Ciardo
LSLuigi Santoro
Luigi Santoro
RORoberto Orecchia
Roberto Orecchia

1 July 2017 in Physica Medica
Verified
Journal Article
Closed access
RRRosalinda Ricotti
Rosalinda Ricotti
DCDelia Ciardo
Delia Ciardo
FPFloriana Pansini
Floriana Pansini
ABAlessia Bazani
Alessia Bazani
SCStefania Comi
Stefania Comi
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa

30 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
LPLorenzo Placidi
Lorenzo Placidi
EGEliana Gioscio
Eliana Gioscio
CGCristina Garibaldi
Cristina Garibaldi
TRTiziana Rancati
Tiziana Rancati
AFAnnarita Fanizzi
Annarita Fanizzi
MAMichele Avanzo
Michele Avanzo
Dosiomics is a texture analysis method to produce dose features that encode the spatial 3D distribution of radiotherapy dose. Dosiomic studies, in a multicentre setting, require assessing the features’ stability to dose calculation settings and the features’ capability in distinguishing different dose distributions. Dose distributions were generated by eight Italian centres on a shared image dataset acquired on a dedicated phantom. Treatment planning protocols, in terms of planning target volume coverage and dose–volume constraints to the organs at risk, were shared among the centres to produce comparable dose distributions for measuring reproducibility/stability and sensitivity of dosiomic features. In addition, coefficient of variation (CV) was employed to evaluate the dosiomic features’ variation. We extracted 38,160 features from 30 different dose distributions from six regions of interest, grouped by four features’ families. A selected group of features (CV < 3 for the reproducibility/stability studies, CV > 1 for the sensitivity studies) were identified to support future multicentre studies, assuring both stable features when dose distributions variation is minimal and sensitive features when dose distribution variations need to be clearly identified. Dosiomic is a promising tool that could support multicentre studies, especially for predictive models, and encode the spatial and statistical characteristics of the 3D dose distribution.

1 September 2014 in Brachytherapy
Verified
Journal Article
Closed access
LCLuigi De Cicco
Luigi De Cicco
BVBarbara Vischioni
Barbara Vischioni
AVAndrea Vavassori
Andrea Vavassori
FGFederica Gherardi
Federica Gherardi
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
RORoberto Orecchia
Roberto Orecchia